Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant Pathogens
dc.contributor.author | Denys, Gerald A. | |
dc.contributor.author | Pillar, Chris M. | |
dc.contributor.author | Sahm, Daniel F. | |
dc.contributor.author | O'Hanley, Peter | |
dc.contributor.author | Stephens, Jackson T. Jr | |
dc.contributor.department | Department of Pathology & Laboratory Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2016-03-21T22:11:31Z | |
dc.date.available | 2016-03-21T22:11:31Z | |
dc.date.issued | 2014-08 | |
dc.description.abstract | This study summarizes the topical E-101 solution susceptibility testing results for 760 Gram-positive and Gram-negative target pathogens collected from 75 U.S. sites between 2008 and 2012 and 103 ESKAPE pathogens. E-101 solution maintained potent activity against all bacterial species studied for each year tested, with MICs ranging from <0.008 to 0.25 μg porcine myeloperoxidase (pMPO)/ml. These results confirm that E-101 solution retains its potent broad-spectrum activity against U.S. clinical isolates and organisms with challenging resistance phenotypes. | en_US |
dc.identifier.citation | Denys, G. A., Pillar, C. M., Sahm, D. F., O’Hanley, P., & Stephens, J. T. (2014). Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant Pathogens. Antimicrobial Agents and Chemotherapy, 58(8), 4911–4914. http://doi.org/10.1128/AAC.03020-14 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/8961 | |
dc.language.iso | en_US | en_US |
dc.publisher | American Society for Microbiology (ASM) | en_US |
dc.relation.isversionof | 10.1128/AAC.03020-14 | en_US |
dc.relation.journal | Antimicrobial Agents and Chemotherapy | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Anti-Infective Agents | en_US |
dc.subject | Drug Resistance, Multiple, Bacterial | en_US |
dc.subject | Glucose Oxidase | en_US |
dc.subject | Gram-Negative Bacteria | en_US |
dc.subject | Gram-Negative Bacterial Infections | en_US |
dc.subject | Humans | en_US |
dc.subject | Hydrogen Peroxide | en_US |
dc.subject | Hypochlorous Acid | en_US |
dc.subject | Longitudinal Studies | en_US |
dc.subject | Microbial Sensitivity Tests | en_US |
dc.subject | Oxidation-Reduction | en_US |
dc.subject | Peroxidase | en_US |
dc.subject | Pharmaceutical Solutions | en_US |
dc.subject | Singlet Oxygen | en_US |
dc.title | Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant Pathogens | en_US |
dc.type | Article | en_US |